Dr. Shivprakash Rathnam, Managing Director
Over the last couple of decades, the Indian clinical research sector has evolved into one of the prominent global destinations, competing with most developed countries. Driven by the globalization of clinical trials and growing disease variations, the industry witnessed an astounding growth of 1414 percent between 2003 and 2010 in the country. In 2009, India emerged into the most favorable location for the creation of new jobs in R&D, unseating U.S. and China which used to dominate the clinic trial scene, even surpassing the predictions of the UNCTAD survey that forecasted India to capture the third spot for the same. Having built their capacity and talent to cater to the whole world, today several Contract Research Organizations (CRO) in India have been witnessing a steady growth, owing to their proficiency in new technologies in clinical research. Our talented scientists are being sought by the largest international corporations for running their global trials and registering their products around the globe.
India’s Clinical Trials, the Industry Everyone is Eyeing On
By: Anamika Sahu, Managing Editor
The world has never understood the importance of clinical trials more than now, since the world is quite eagerly waiting for the coronavirus vaccine. Several
Infection Control In The Covid-19 Era: Fighting The Pandemic Together
By: Kapil N, Co-Founder & CEO, Indicare Health Solutions
The certain increase in COVID 19 patients has put up the immense strain on the healthcare industries and healthcare professionals, globally.
By: Alok Awasthi, Founder, Seekmed
According to Black Book Market Research, data security breaches costing the healthcare industry reached the $4B mark in 2019. This is the highest exposure compared to other
By: Manoj Jagathmohan, Director, Qiagen
Over the few decades, Molecular Testing has dynamically changed the paradigm and has been the fastest growing segment across the broad-er diagnostic market,
By: Paras Arora, Co-Founder & CEO, Qdesq
The pandemic of the new decade is the cause of severe distress globally. Covid-19, commonly known as coronavirus, has affected many in India and is consistently straining daily functioning.
By: Arun Rangamani, SVP- Analytics & Technology, Scio Health Analytics
Healthcare across developed world and partially in the developing world is in the midst of what industry specialists'
By: Dr Amit Saraf, Doctor, Jupiter Hospital
The term "Artificial intelligence (AI)"was coined in the year 1956. Since then extensive research was undertaken, initially focusing on problem solving and symbolic methods, and then gradually
By: Pooja Nagdev, Cosmetologist And Aromatherapist, Founder, Inatur Ayurveda & Aromatherapy
Life has come to a standstill and busiest and the most buzzing towns and spots have become desolate locked down places.
By: Dt. Shikha Mahajan, Holistic Nutritionist And Founder, Diet Podium
Coronavirus has taken the world a hostage and is rightly the only topic discussed. Every person, directly or indirectly, has been affected by
By: Vipul Jain, CEO, Advancells
A few years ago, if you would have asked anyone about the adult stem cells, he would have had no idea what are you talking about and might have thought that you were referring
Top 10 Clinical Trials Service Providers - 2020
According to grandviewresearch.com, almost 16 percent of the worldwide population is dependent on Indian clinical trials, and about 20 percent of the disease burden around the globe. However, only a fraction, less than 1.4 percent of the total global clinical trials are carried out in India because of lack of proper regulations. But, in recent times, the amendments in regulations forwarded by the Central Drugs Standard Control Organization (CDSCO), which include reduced approval period, and online registry, are predicted to drive the market growth. Factors such as the digitalization of clinical trials are projected to enhance the growth of the sector, where digitalization has streamlined several clinical trials methodologies like data capture, regulatory compliance, logistics, and supplies management, among others. Even so that the introduction of digital therapeutics, real-time data capture adhering to safety, and toxicity has been an easy process, which also promotes timely corrections in trial design, henceforth facilitates the market growth. When it comes to the Indian clinical trials market size, it was estimated at USD 1.6 billion in 2017. Increasing at a CAGR of 8.7 percent, the Indian clinical trials market size is expected to reach USD 3.15 billion by 2025. Enhancement in clinical trials globally, and a rapid increase in disease fluctuations, and occurrence, are projected to contribute to the clinical trial market. As there has been increasing new technology adoption in clinical research, and overwhelming R&D rise, promoting outsourcing, the Indian clinical trial industry is placed at the second position, following China, in terms of the patient population for clinical trials (by an Institute for Studies in Industrial Development report). The cost is also low in India (nearly half) than that is in the United States, and Europe. Bestowed to these reasons of finance, and geography, the Indian clinical trial industry is a booming sector. Recognizing the market trends, and domination, in this issue of the CEO Insights magazine, we present a list of ‘Top 10 Clinical Trials Service Providers - 2020’, featuring some of the top-notch companies. The listing is prepared by industry veterans, CEOs, and VCs, and the CEO Insights magazine editorial board. It delineates the names of the firms finding new and better cures for diseases.
|Company Logo||Company Management||Company Name||Company Description|
|Chandu Devanpally,Founder & MD||Ardent Clinical Research Services||An integrated, full service CRO attributing the space of clinical research via its advanced in-house software and clinical trial management solutions & services.|
|Satish Marakurthi,Founder & CEO||Croissance Clinical Research||A full-fledged Clinical Research Organization, providing services to pharmaceutical, biotechnology, and medical devices companies.|
|Dhirendra Vikram Singh,Managing Director||Genelife Clinical Research||Affording clinical services like phase i clinical trials, phase ii clinical trials, phase iii clinical trials, phase iv clinical trials, medical writing, statistical analysis, data management, project management, quality assurance, pharmacovigilance, regulatory affairs, site management, and consultancy services.|
|D.T. Arasu,Managing Director||iDD Research Solutions||A CRO working on changing the dynamics of clinical trials via its in-house developed software, and clinical trial management solutions & services iSMART.|
|Dr. Upendra K. Jain,Founder & CEO||Indivirtus||The company offers services such as health-based exposure limit assessment, eCTD, CTD, pharmacovigilance, GxP services, health economics and outcome research, medical billing, and coding.|
|Dr. Prabhakar Y. Naik,Co-Founder, Director & CEO||INTOX||Nurturing study solutions like general toxicity, reproductive toxicity, special toxicity studies, environmental toxicity, and biocompatibility studies for medical devices.|
|Dr Sunil K Tadepalli,MD||Labnetworx||Provider of consulting in healthcare, life sciences, pharmaceuticals and information technology.|
|Srinivasan H R,Vice Chairman and Managing Director||Navitas Life Sciences||Facilitates services like clinical research, generics development, data sciences, regulatory affairs, pharmacovigilance and safety, strategic consulting, and industry networks.|
|Sri Vatsa GS,MD||Samahitha Research Solutions||A quality & time stipulated drug discovery, research, and clinical trial services company working within the framework of good clinical practices, dedicatedly helping build a secure healthcare system.|
|Dr. Shivprakash Rathnam,Managing Director||Synchron Research Services||Leveraging a wide array of services like phase I/IIa BA/BE, phase II/IV, bioanalysis, biostatistics, and data management, and quality analysis.|